LSF (also named CP2), previously characterized widely as a transcription factor, is an oncogene in hepatocellular carcinoma that is significantly overexpressed in hepatocellular carcinoma cell lines and patient samples (23, –, 28) as well as in other cancer types (29). Here, TFCP2 is linked to hepatocellular carcinoma.